Labeled for this condition
Medicines for covid-19
5 medicines have an FDA label indicated for COVID-19; 0 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for covid-19?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Tocilizumab | Tyenne, Tofidence, Actemra | none listed | $821.00 per mL 162 mg/0.9 mL autoinjct | Yes | No current entry | 1 |
| Nirmatrelvir and ritonavir | Paxlovid | none listed | $49.24 per unit 300-100 mg dose pack | Yes | No current entry | 0 |
| Baricitinib | Olumiant | none listed | $92.54 per tablet 2 mg tablet | Yes | No current entry | 0 |
| Ensitrelvir | Xocova | none listed | n/a | No | No current entry | 0 |
| Remdesivir | Veklury | none listed | n/a | No | No current entry | 2 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price